MAS063DP is Effective Monotherapy for Mild to Moderate Atopic Dermatitis in Infants and Children: A Multicenter, Randomized, Vehicle-Controlled Study
- 30 June 2008
- journal article
- research article
- Published by Elsevier BV in The Journal of Pediatrics
- Vol. 152 (6), 854-859
- https://doi.org/10.1016/j.jpeds.2007.11.031
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- New perspectives on epidermal barrier dysfunction in atopic dermatitis: Gene–environment interactionsJournal of Allergy and Clinical Immunology, 2006
- The use of topical calcineurin inhibitors in dermatology: Safety concerns: Report of the American Academy of Dermatology Association Task ForceJournal of the American Academy of Dermatology, 2006
- Epidermal barrier formation and recovery in skin disordersJCI Insight, 2006
- Patient perspectives on the management of atopic dermatitisJournal of Allergy and Clinical Immunology, 2006
- Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitisNature Genetics, 2006
- Effects of Atopic Dermatitis on Young American Children and Their FamiliesPublished by American Academy of Pediatrics (AAP) ,2004
- Genetic Association Between an AACC Insertion in the 3′UTR of the Stratum Corneum Chymotryptic Enzyme Gene and Atopic DermatitisJournal of Investigative Dermatology, 2004
- Efficacy of a Topical Agent, MAS063D (‘Atopiclair’), in the Treatment of Sodium Lauryl Sulphate-Induced Irritant Contact DermatitisExogenous Dermatology, 2003
- The eczema area and severity index (EASI): assessment of reliability in atopic dermatitisExperimental Dermatology, 2001
- HYALURONIC ACID AND SKIN: WOUND HEALING AND AGINGInternational Journal of Dermatology, 1996